Clinical Research Directory
Browse clinical research sites, groups, and studies.
Registry Study on Prescription, Patient Pathways, Therapy Efficacy and Usage of Mandibular Advancement Devices in Obstructive Sleep Apnea - PATT-OSA Registry
Sponsor: ResMed
Summary
During sleep, the muscle tonus in the oropharyngeal space is lost, the tongue might fall back andthe volume of the pharynx decreases. Air cannot pass through as it would in the awake state and thus airflow limitations occur. The person asleep might compensate the flow limitation by breathing faster, which causes the soft tissue to vibrate (= snoring). Further narrowing of the airways can lead to obstructive apneas (complete airway collapse and stopping of airflow). First line therapy for obstructive sleep apnea (OSA) is positive airway pressure (PAP) that keeps the airways open with a pneumatic splint. Since PAP involves wearing a facial mask that applies air pressure into the airways, some patients cannot tolerate this therapy. These patients might be candidates for an alternative treatment approach with a mandibular advancement device (MAD).
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2024-02-01
Completion Date
2025-06-30
Last Updated
2024-10-29
Healthy Volunteers
No
Conditions
Locations (4)
Schlaf- und Beatmungszentrum Blaubeuren
Blaubeuren Abbey, Badden-Württemberg, Germany
Ruhrlandklinik Essen
Essen, North Rhine-Westphalia, Germany
Zentrum für Schlafmedizin Dr. Warmuth
Berlin, Germany
Universitätsklinikum Regensburg - Klinik für Innere Medizin II
Regensburg, Germany